Detalles de la búsqueda
1.
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
Am Heart J
; 273: 35-43, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38641031
2.
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
Lancet
; 396(10257): 1079-1089, 2020 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32882163
3.
Clinical Implications of Bifurcation Angles in Left Main Bifurcation Intervention Using a Two-Stent Technique.
J Interv Cardiol
; 2020: 2475930, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32733170
4.
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stentã- 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.
Circ J
; 83(7): 1489-1497, 2019 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31155604
5.
Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel Study.
Chonnam Med J
; 60(1): 78-86, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38304131
6.
Intravascular Ultrasound Guided Intervention in Calcified Coronary Lesions Showed Good Clinical Outcomes during One Year Follow-Up.
J Clin Med
; 12(12)2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37373765
7.
Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry.
Cardiol J
; 30(1): 105-116, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634845
8.
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial.
Eur Heart J Cardiovasc Pharmacother
; 9(3): 262-270, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715152
9.
The Clinical Impact of ß-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention.
Korean Circ J
; 52(7): 544-555, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491482
10.
Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome.
Circ J
; 75(9): 2120-7, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21757819
11.
Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor.
J Korean Med Sci
; 25(11): 1601-8, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21060749
12.
Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction.
J Korean Med Sci
; 25(10): 1456-61, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20890426
13.
Optimal Dose and Type of ß-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Am J Cardiol
; 137: 12-19, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32998005
14.
Clinical effects of hypertension on the mortality of patients with acute myocardial infarction.
J Korean Med Sci
; 24(5): 800-6, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19794974
15.
Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease.
Korean Circ J
; 49(8): 709-720, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31165595
16.
Safety and Efficacy of the Endeavor Resolute® Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter Trial.
Chonnam Med J
; 54(1): 55-62, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29399567
17.
Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study).
Yonsei Med J
; 59(1): 72-79, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29214779
18.
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study.
Clin Ther
; 40(5): 676-691.e1, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29673890
19.
Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort.
Circ Cardiovasc Interv
; 10(11)2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29146671
20.
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.
Trials
; 16: 409, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26374625